United States Biotechnology & Medical Research

Arrivent Biopharma Inc (AVBP)

Track

Track

Ticker: AVBP Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Arrivent Biopharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.6
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
258.54
Quantity 63,795 -9.9%
Value US$4,094,982
1.6
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 222,222 +17.2%
Value US$3,999,996
2.9
HEALY JAMES Non-Executive Director
Transaction date
Purchase
Price
18.00
Quantity 444,444 +35.5%
Value US$7,999,992
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 222,222 +17.2%
Value US$3,999,996
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 222,222 +17.2%
Value US$3,999,996
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-03 2025-12-10 S Sale
1.6
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
Large shareholder
40,435 +24.5%
449.36
US$1,011,716 		40,435 +24.5% 449.36 US$1,011,716
2024-02-01 2024-01-30 B Purchase
1.6
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
Large shareholder
20,100 +33.1%
320.22
US$4,848,610 		20,100 +33.1% 320.22 US$4,848,610
2024-01-31 2024-01-30 B Purchase
1.6
GORDON CARL L
Non-Executive Director Large shareholder
63,795 -9.9%
258.54
US$4,094,982 		63,795 -9.9% 258.54 US$4,094,982
2024-01-31 2024-01-30 B Purchase
1.6
GORDON CARL L
Non-Executive Director Large shareholder
222,222 +17.2%
18.00
US$3,999,996 		222,222 +17.2% 18.00 US$3,999,996
2024-01-31 2024-01-30 B Purchase
2.9
HEALY JAMES
Non-Executive Director
444,444 +35.5%
18.00
US$7,999,992 		444,444 +35.5% 18.00 US$7,999,992
2024-01-31 2024-01-30 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
222,222 +17.2%
18.00
US$3,999,996 		222,222 +17.2% 18.00 US$3,999,996
2024-01-31 2024-01-30 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
222,222 +17.2%
18.00
US$3,999,996 		222,222 +17.2% 18.00 US$3,999,996
Explore more

More insider trading research around Arrivent Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America